Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension (OSCAR)

Pfizer

Status and phase: Completed; Phase 3

Conditions: Essential Hypertension

Treatments: Drug: olmesartan alone or in combination with hydrochlorothiazide

Study type: Interventional

Funder types: Industry

Identifiers

NCT00139698

A0021002

Details and patient eligibility

About

Efficacy, tolerability and safety of olmesartan alone or in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject has mild to moderate hypertension

Exclusion criteria

• History of secondary hypertension

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)